• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨基质调节蛋白在人类动脉粥样硬化斑块中的差异表达。

Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.

作者信息

Dhore C R, Cleutjens J P, Lutgens E, Cleutjens K B, Geusens P P, Kitslaar P J, Tordoir J H, Spronk H M, Vermeer C, Daemen M J

机构信息

Department of Pathology, Cardiovascular Research Institute Maastricht, University of Maastricht, Netherlands.

出版信息

Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1998-2003. doi: 10.1161/hq1201.100229.

DOI:10.1161/hq1201.100229
PMID:11742876
Abstract

In the present study, we examined the expression of regulators of bone formation and osteoclastogenesis in human atherosclerosis because accumulating evidence suggests that atherosclerotic calcification shares features with bone calcification. The most striking finding of this study was the constitutive immunoreactivity of matrix Gla protein, osteocalcin, and bone sialoprotein in nondiseased aortas and the absence of bone morphogenetic protein (BMP)-2, BMP-4, osteopontin, and osteonectin in nondiseased aortas and early atherosclerotic lesions. When atherosclerotic plaques demonstrated calcification or bone formation, BMP-2, BMP-4, osteopontin, and osteonectin were upregulated. Interestingly, this upregulation was associated with a sustained immunoreactivity of matrix Gla protein, osteocalcin, and bone sialoprotein. The 2 modulators of osteoclastogenesis (osteoprotegerin [OPG] and its ligand, OPGL) were present in the nondiseased vessel wall and in early atherosclerotic lesions. In advanced calcified lesions, OPG was present in bone structures, whereas OPGL was only present in the extracellular matrix surrounding calcium deposits. The observed expression patterns suggest a tight regulation of the expression of bone matrix regulatory proteins during human atherogenesis. The expression pattern of both OPG and OPGL during atherogenesis might suggest a regulatory role of these proteins not only in osteoclastogenesis but also in atherosclerotic calcification.

摘要

在本研究中,我们检测了人类动脉粥样硬化中骨形成和破骨细胞生成调节因子的表达情况,因为越来越多的证据表明动脉粥样硬化钙化与骨钙化具有共同特征。本研究最显著的发现是,在未患病的主动脉中,基质Gla蛋白、骨钙素和骨唾液蛋白呈组成性免疫反应性,而在未患病的主动脉和早期动脉粥样硬化病变中,骨形态发生蛋白(BMP)-2、BMP-4、骨桥蛋白和骨连接蛋白缺失。当动脉粥样硬化斑块出现钙化或骨形成时,BMP-2、BMP-4、骨桥蛋白和骨连接蛋白上调。有趣的是,这种上调与基质Gla蛋白、骨钙素和骨唾液蛋白的持续免疫反应性相关。破骨细胞生成的两种调节因子(骨保护素[OPG]及其配体OPGL)存在于未患病的血管壁和早期动脉粥样硬化病变中。在晚期钙化病变中,OPG存在于骨结构中,而OPGL仅存在于钙沉积物周围的细胞外基质中。观察到的表达模式表明,在人类动脉粥样硬化发生过程中,骨基质调节蛋白的表达受到严格调控。动脉粥样硬化发生过程中OPG和OPGL的表达模式可能表明这些蛋白不仅在破骨细胞生成中起调节作用,而且在动脉粥样硬化钙化中也起调节作用。

相似文献

1
Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.骨基质调节蛋白在人类动脉粥样硬化斑块中的差异表达。
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1998-2003. doi: 10.1161/hq1201.100229.
2
Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis.骨保护素、肿瘤坏死因子相关凋亡诱导配体及核因子κB受体激活剂配体在门克贝格氏硬化症和动脉粥样硬化中的定位
J Clin Endocrinol Metab. 2004 Aug;89(8):4104-12. doi: 10.1210/jc.2003-031432.
3
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment.骨髓瘤细胞在人类骨髓环境中诱导骨保护素/骨保护素配体系统失衡。
Blood. 2001 Dec 15;98(13):3527-33. doi: 10.1182/blood.v98.13.3527.
4
CSF-1, RANKL and OPG regulate osteoclastogenesis during murine tooth eruption.集落刺激因子-1、核因子κB受体活化因子配体和骨保护素在小鼠牙齿萌出过程中调节破骨细胞生成。
Arch Oral Biol. 2005 Oct;50(10):897-908. doi: 10.1016/j.archoralbio.2005.02.007. Epub 2005 Apr 9.
5
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.骨巨细胞瘤中骨保护素配体、骨保护素及核因子κB受体激活剂的基因表达:可能参与肿瘤细胞诱导的破骨样细胞形成。
Am J Pathol. 2000 Mar;156(3):761-7. doi: 10.1016/s0002-9440(10)64942-5.
6
Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat.大鼠股骨和胫骨中骨保护素(OPG)及其配体(RANKL)mRNA和蛋白的检测。
J Mol Histol. 2005 Feb;36(1-2):59-67. doi: 10.1007/s10735-004-3839-1.
7
Osteoprotegerin and rank ligand expression in prostate cancer.骨保护素与前列腺癌中核因子κB受体活化因子配体的表达
Urology. 2001 Apr;57(4):611-6. doi: 10.1016/s0090-4295(00)01122-5.
8
Expression of bone-regulatory proteins in human valve allografts.骨调节蛋白在人同种异体瓣膜中的表达。
Heart. 2006 Sep;92(9):1303-8. doi: 10.1136/hrt.2005.075903. Epub 2006 Jan 31.
9
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice.骨保护素失活加速老年载脂蛋白E基因敲除小鼠晚期动脉粥样硬化病变进展和钙化。
Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2117-24. doi: 10.1161/01.ATV.0000236428.91125.e6. Epub 2006 Jul 13.
10
Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand.成骨细胞为核因子κB受体活化因子配体的作用提供了适宜的微环境。
Endocrinology. 2006 Jul;147(7):3366-74. doi: 10.1210/en.2006-0216. Epub 2006 Apr 20.

引用本文的文献

1
Osteoprotegerin and its ligands RANKL and TRAIL in falciparum, vivax, and knowlesi malaria.恶性疟、间日疟和诺氏疟中的骨保护素及其配体RANKL和TRAIL
iScience. 2025 May 27;28(6):112768. doi: 10.1016/j.isci.2025.112768. eCollection 2025 Jun 20.
2
Macrophage-driven exosomes regulate the progression of cardiovascular disease.巨噬细胞驱动的外泌体调节心血管疾病的进展。
Front Pharmacol. 2025 Apr 30;16:1563800. doi: 10.3389/fphar.2025.1563800. eCollection 2025.
3
High-Density Lipoproteins from Coronary Artery Disease and Aortic Valve Stenosis Patients Differentially Regulate Gene Expression in a Model of Cardiac Adipocytes.
来自冠心病和主动脉瓣狭窄患者的高密度脂蛋白对心脏脂肪细胞模型中的基因表达有不同调节作用。
Cells. 2025 Jan 30;14(3):205. doi: 10.3390/cells14030205.
4
Osteoprotegerin as an Emerging Biomarker of Carotid Artery Stenosis? A Scoping Review with Meta-Analysis.骨保护素作为颈动脉狭窄的一种新兴生物标志物?一项包含荟萃分析的范围综述。
Diagnostics (Basel). 2025 Jan 19;15(2):219. doi: 10.3390/diagnostics15020219.
5
Osteoprotegerin (OPG) and its ligands RANKL and TRAIL in falciparum, vivax and knowlesi malaria: correlations with disease severity, and B cell production of OPG.恶性疟、间日疟和诺氏疟中的骨保护素(OPG)及其配体RANKL和TRAIL:与疾病严重程度的相关性以及B细胞对OPG的产生
medRxiv. 2024 Jul 23:2024.07.22.24310838. doi: 10.1101/2024.07.22.24310838.
6
The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review.他汀类药物对血管钙化的复杂机制及潜在影响:一项叙述性综述
Rev Cardiovasc Med. 2024 Jan 30;25(2):51. doi: 10.31083/j.rcm2502051. eCollection 2024 Feb.
7
Calcinosis Prevalence in Autoimmune Connective Tissue Diseases-A Retrospective Study.自身免疫性结缔组织病中钙质沉着症的患病率——一项回顾性研究
J Clin Med. 2024 Jun 12;13(12):3428. doi: 10.3390/jcm13123428.
8
Divergent and Compensatory Effects of BMP2 and BMP4 on the VSMC Phenotype and BMP4's Role in Thoracic Aortic Aneurysm Development.BMP2 和 BMP4 对 VSMC 表型的差异和补偿作用以及 BMP4 在胸主动脉瘤发展中的作用。
Cells. 2024 Apr 24;13(9):735. doi: 10.3390/cells13090735.
9
Coronary artery calcification and plaque stability: an optical coherence tomography study.冠状动脉钙化与斑块稳定性:一项光学相干断层扫描研究
Heliyon. 2023 Dec 3;9(12):e23191. doi: 10.1016/j.heliyon.2023.e23191. eCollection 2023 Dec.
10
Beyond the Basics: Unraveling the Complexity of Coronary Artery Calcification.超越基础:揭开冠状动脉钙化的复杂性。
Cells. 2023 Dec 12;12(24):2822. doi: 10.3390/cells12242822.